BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

448 related articles for article (PubMed ID: 10690041)

  • 1. A review of Waldenstrom's macroglobulinemia.
    McDermott MK; Bell EM
    Clin J Oncol Nurs; 1999 Jul; 3(3):107-11. PubMed ID: 10690041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uniform response criteria in Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia.
    Weber D; Treon SP; Emmanouilides C; Branagan AR; Byrd JC; Bladé J; Kimby E
    Semin Oncol; 2003 Apr; 30(2):127-31. PubMed ID: 12720121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Waldenström's macroglobulinemia.
    McKenna JA
    Clin J Oncol Nurs; 2002; 6(5):283-6. PubMed ID: 12240489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment recommendations in Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia.
    Gertz MA; Anagnostopoulos A; Anderson K; Branagan AR; Coleman M; Frankel SR; Giralt S; Levine T; Munshi N; Pestronk A; Rajkumar V; Treon SP
    Semin Oncol; 2003 Apr; 30(2):121-6. PubMed ID: 12720120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recognizing hyperviscosity syndrome in patients with Waldenstrom macroglobulinemia.
    Mullen EC; Wang M
    Clin J Oncol Nurs; 2007 Feb; 11(1):87-95. PubMed ID: 17441400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stem cell transplantation (SCT) for Waldenstrom's macroglobulinemia (WM).
    Anagnostopoulos A; Giralt S
    Bone Marrow Transplant; 2002 Jun; 29(12):943-7. PubMed ID: 12098060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymphoplasmacytic lymphoma-Waldenstrom's macroglobulinemia.
    Vitolo U; Ferreri AJ; Montoto S
    Crit Rev Oncol Hematol; 2008 Aug; 67(2):172-85. PubMed ID: 18499469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic markers and criteria to initiate therapy in Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia.
    Kyle RA; Treon SP; Alexanian R; Barlogie B; Björkholm M; Dhodapkar M; Lister TA; Merlini G; Morel P; Stone M; Branagan AR; Leblond V
    Semin Oncol; 2003 Apr; 30(2):116-20. PubMed ID: 12720119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Waldenström's macroglobulinemia.
    Dimopoulos MA; Anagnostopoulos A
    Best Pract Res Clin Haematol; 2005; 18(4):747-65. PubMed ID: 16026748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosis and management of Waldenstrom's macroglobulinemia.
    Dimopoulos MA; Kyle RA; Anagnostopoulos A; Treon SP
    J Clin Oncol; 2005 Mar; 23(7):1564-77. PubMed ID: 15735132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Waldenström's macroglobulinemia: clinical course and prognostic factors in 60 patients. Experience from a single hematology unit.
    Kyrtsonis MC; Vassilakopoulos TP; Angelopoulou MK; Siakantaris P; Kontopidou FN; Dimopoulou MN; Boussiotis V; Gribabis A; Konstantopoulos K; Vaiopoulos GA; Fessas P; Kittas C; Pangalis GA
    Ann Hematol; 2001 Dec; 80(12):722-7. PubMed ID: 11797112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Asymptomatic Waldenstrom's macroglobulinemia.
    Alexanian R; Weber D; Delasalle K; Cabanillas F; Dimopoulos M
    Semin Oncol; 2003 Apr; 30(2):206-10. PubMed ID: 12720137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Waldenstrom's macroglobulinemia presenting with spinal cord compression: a case report.
    Al-Halabi H; Roberge D
    Am J Hematol; 2006 Dec; 81(12):955-8. PubMed ID: 16888782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patterns of clinical presentation, treatment, and outcome in patients with Waldenstrom's macroglobulinemia: a two-institution study.
    Björkholm M; Johansson E; Papamichael D; Celsing F; Matthews J; Lister TA; Rohatiner AZ
    Semin Oncol; 2003 Apr; 30(2):226-30. PubMed ID: 12720141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Waldenström's macroglobulinemia: a clinicopathologic study of 22 cases.
    Andriko JA; Aguilera NS; Chu WS; Nandedkar MA; Cotelingam JD
    Cancer; 1997 Nov; 80(10):1926-35. PubMed ID: 9366295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicopathological definition of Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia.
    Owen RG; Treon SP; Al-Katib A; Fonseca R; Greipp PR; McMaster ML; Morra E; Pangalis GA; San Miguel JF; Branagan AR; Dimopoulos MA
    Semin Oncol; 2003 Apr; 30(2):110-5. PubMed ID: 12720118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD20-directed antibody-mediated immunotherapy induces responses and facilitates hematologic recovery in patients with Waldenstrom's macroglobulinemia.
    Treon SP; Agus TB; Link B; Rodrigues G; Molina A; Lacy MQ; Fisher DC; Emmanouilides C; Richards AI; Clark B; Lucas MS; Schlossman R; Schenkein D; Lin B; Kimby E; Anderson KC; Byrd JC
    J Immunother; 2001; 24(3):272-9. PubMed ID: 11394506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Waldenström's macroglobulinemia as a diagnostic challenge: case report.
    Budimir I; Nikolić M; Pusić MS; Hrabar D; Ljubicić N; Duvnjak M; Supanc V; Nikolac I; Babić N; Sokcević M
    Acta Clin Croat; 2014 Mar; 53(1):94-7. PubMed ID: 24974671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential diagnosis of Waldenstrom's macroglobulinemia from other low-grade B-cell lymphoproliferative disorders.
    Pangalis GA; Kyrtsonis MC; Kontopidou FN; Vassilakopoulos TP; Siakantaris MP; Dimopoulou MN; Kittas C; Angelopoulou MK
    Semin Oncol; 2003 Apr; 30(2):201-5. PubMed ID: 12720136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunochemical studies in a patient with Waldenstrom's macroglobulinemia.
    Mir-Ahmadian M; Rahbar S; Heidery H; Hajaliloo G
    Acta Med Iran; 1978; 21(1):39-46. PubMed ID: 110036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.